Table 5.
Postoperative complications
Complications | Diprospan group | Placebo group | Control group | P value* | P value*? |
Pulmonary | |||||
-Bronchospasm | 2 | 3 | 1 | ||
-Pneumonia | 1 | 1 | 1 | ||
-Atelectasis | 1 | 0 | 0 | ||
-Pleural effusion | 1 | 0 | 2 | ||
-Pneumothorax | 0 | 1 | 0 | ||
-Respiratory failure | 1 | 1 | 1 | ||
Total pulmonary | 6(20%) | 6 (20%) | 5 (10%) | 0.56 | 0.02 |
Nonpulmonary | |||||
Major | |||||
- Wound infection | 2 | 4 | 0 | ||
- Acute renal failure | 1 | 0 | 0 | ||
- Stroke | 1 | 2 | 0 | ||
- Sepsis | 0 | 1 | 0 | ||
- Re-surgery | 1 | 1 | 2 | ||
Total major | 5 (17%) | 8 (26%) | 2 (7%) | 0.8 | 0.03 |
Minor | |||||
- Atrial | 11 | 8 | 1 | ||
tachyarrhythmias - | |||||
Superficial wound | 4 | 3 | 4 | ||
infection | |||||
- Transient oliguria | 1 | 2 | 3 | ||
- Urinary tract infection | 0 | 1 | 0 | ||
- Acute gout | 0 | 1 | 0 | ||
Total minor | 16 (53%) | 15 (50%) | 8 (27%) | 0.1 | 0.01 |
Total nonpulmonary | 21 (70%) | 23 (76%) | 10 (33%) | 0.79 | 0.01 |
* Between Diprospan and placebo groups.
** Between Control and COPD groups.